5α-Reductase Inhibitor Therapy: Should Physicians Be Concerned With Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients?

    October 2010 in “ Journal of Men's Health ”
    M TraishAbdulmaged, HassaniJohn, T GuayAndre, ZitzmannMichael, L HansenMichael
    Image of study
    TLDR Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.
    The document discusses the potential adverse effects of 5α-reductase inhibitor therapy, which is used to treat androgenetic alopecia (hair loss) and benign prostatic hypertrophy (BPH). The therapy has been shown to be effective in preventing hair loss and improving urinary symptoms while reducing prostate size. However, it may also lead to serious side effects, including diminished libido, erectile and ejaculatory dysfunction, depression, and other behavioral and cardiovascular events. Some of these effects may be irreversible and can significantly impact the quality of life of individual patients. The study emphasizes the importance of physicians discussing these potential risks with patients before starting treatment, as the adverse effects can persist or become irreversible in some cases, and patients may not recover even after discontinuing the drugs. Alternative treatments should be considered and thoroughly addressed with the patient.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 92 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Another clueless guy fearmongering and spreading misinformation

      in Chat  251 upvotes 10 months ago
      The conversation discusses hair loss treatments, with some users advocating for finasteride and minoxidil, while others express concerns about potential side effects of finasteride. A social media influencer is criticized for promoting scalp massages and minoxidil over finasteride, which some believe is misinformation.

    Similar Research

    5 / 1000+ results